Diabetes (hyperglycemia) incidence is increasing drastically. For individuals born in 2000, the lifetime risk of diabetes in the U.S. is 33%, and over 16 million in the U.S. currently have diabetes, while over 54 million have insulin resistance or pre-diabetes. Childhood diabetes is increasing even more rapidly than adult diabetes. Over the last 20 years, the percent of diabetes cases below 20-years-old has increased from 2% to over 30%, and there was a 70% increase in cases under 40 years of age between 1990 and 1998. Studies in the U.S. and Europe have found toxic metals and vaccinations to be factors in the increased diabetes cases, along with poor dietary habits. A greatly increased incidence of juvenile diabetes has been correlated to specific vaccination sequences and to the number of vaccines given. Autoimmune diseases with a predominant Th1 cytokine component involvement in some cases include insulin-dependent diabetes mellitus. Incidence of insulin resistance as a factor in many chronic conditions has also increased significantly. Diabetes and pre-diabetes are conditions rather than diseases and usually can be prevented or controlled.
There are 2 basic types of diabetes, Type I (autoimmune) diabetes and Type II (insulin resistance). In type I diabetes, the body’s immune system attacks its own insulin producing tissue—the beta cells of the pancreas. Type II diabetes involves metabolic failure related to poor diet, obesity, environmental factors, and genetic susceptibility. Insulin resistance is a primary factor in type 2 diabetes and results when the body cannot properly use insulin, which is secreted by the pancreas to move glucose from the blood into the cells that need it. The pancreas then produces extra insulin in a futile effort to compensate, leading to higher insulin and glucose levels in the blood along with a deficiency of glucose in the cells that need sugar to function properly. Those with either type I or type II diabetes have been found to be more likely to have other chronic conditions, including heart disease, strokes, kidney disease, Alzheimer’s, eye conditions, and blindness.
Causes of Diabetes and the Mercury/Toxic Metal Connection
Type II diabetes and pre-diabetes is an epidemic among young Americans and greatly increases the incidence of heart attack, blindness, stoke, infertility, and early death. Brain inflammation has been found to be a major factor in pre-diabetes, diabetes, and the closely related metabolic syndrome, which includes high blood pressure and high cholesterol. Causes of oxidative stress and lipid peroxidative-related brain inflammation that have been documented include vaccines, mercury, aluminum, excitotoxins, aspartame, food additives, and overconsumption of high-fructose corn sweetener, starches, sweets, and other omega 6 oils. These cause high glutamate levels in the brain and oxidative damage, resulting in inflammation of the brain and immune system as well as damage to brain microglia cells and the mitochondrial DNA, fatigue, high triglycerides, metabolic syndrome, etc. These have been found to be factors in most chronic neurological diseases. Inflammation induced by vaccine adjuvants, like aluminum and mercury, or by excitotoxins, like MSG, has been found to play a significant role in insulin resistance (type II diabetes) and in high levels of LDL cholesterol. There is also evidence that the diet drink sweetener aspartame can cause or increase the effects of diabetes and hypoglycemia. Higher levels of vitamin D have been found to be associated with lower levels of insulin resistance and appear to be protective. Theoflavins from black or green tea and curcumin have been found to be significantly effective in protection against inflammation and inflammatory conditions.
Reduced levels of magnesium and zinc are related to metabolic syndrome, insulin resistance, and brain inflammation and are protective against these conditions. Mercury and cadmium inhibiting magnesium and zinc levels as well as inhibiting glucose transfer are other mechanisms by which mercury and toxic metals are factors in metabolic syndrome and insulin resistance/diabetes. Iron overload has also been found to be a cause of insulin resistance/type II diabetes. Mercury also has synergistic effects with other toxics such as dioxins that have been found to increase insulin resistance more than simply additive effects. Mercury exposure levels from vaccinations have likewise shown major increases during this period and have been found to be a major factor in the increase of other conditions like autism and ADHD. The most common mechanism of causality has been found to be blockage by mercury and other toxic metals of the enzymatic processes related to digestion of milk casein and wheat gluten, resulting in dumping of morphine like substances in the blood of the majority of children with these conditions.
A direct mechanism involving mercury’s inhibition of cellular enzymatic processes by binding with the hydroxyl radical (SH) in amino acids appears to be a major part of the connection to allergic/immune reactive conditions. For example, mercury has been found to strongly inhibit the activity of xanthine oxidase and dipeptyl peptidase (DPP IV) which are required in the digestion of the wheat protein gluten or the milk protein casein—the same protein that is cluster differentiation antigen 26 (CD26), which helps T-lymphocyte activation. CD26 or DPPIV is a cell surface glycoprotein that is very susceptible to inactivation by mercury binding to its cysteinyl domain. Mercury and other toxic metals also inhibit binding of opioid receptor agonists to opioid receptors, while magnesium stimulates binding to opioid receptors.
Beta-casomorphine-7 is a morphine-like compound that results in neural dysfunction, as well as being a direct histamine releaser in humans and inducing skin reactions. A similar mechanism related to mercury and toxic metals blocking the enzymatic processes related to digestion of gluten and casein have also been shown to be a significant factor in causality of children’s type I diabetes. Early introduction of feeding cow’s milk to infants rather than breastfeeding has been shown to be a significant risk factor in type I diabetes incidence.
Most infants in recent years have been found to be exposed to high levels of mercury and toxic metals through vaccines, mother’s amalgam dental fillings, and other sources, with toxic metals documented to block the enzymatic processes needed to digest casein and gluten. Studies have found high levels of Ig A antigen specific antibodies for casein, lactalbumin and beta-lactoglobulin, and IgG and IgM for casein in cow’s milk. In vitro the bioactive peptide beta-casomorphin 7 (BCM-7) is yielded by the successive gastrointestinal proteolytic digestion of bovine beta-casein variants A1 and B, but this was not seen in variant A2.
In hydrolysed milk with variant A1 of beta-casein, BCM-7 level is 4-fold higher than in A2 milk. Consumption of the beta-casein A1 variant had a strong correlation to diabetes incidence (r = +0.726). Even more pronounced was the relation between beta-casein (A1+B) consumption and diabetes (r = +0.982). These latter two cow caseins yield a bioactive peptide beta-casomorphin-7 after in vitro digestion with intestinal enzymes whereas the common A2 variant or the corresponding human or goat caseins do not. BCM-7 has also been found to be a factor in autism and schizophrenia. Mercury and toxic metals have been found to disable the enzymatic process required to digest casein. A1 is the most frequent in Holstein-Friesian (0.310-0.660), Ayrshire (0.432-0.720) and Red (0.710) cattle. In contrast, a high frequency of A2 is observed in Guernsey (0.880-0.970) and Jersey (0.490-0.721) cattle as well as Asian and African cattle. BCM-7 may play a role in the aetiology of many human diseases including diabetes, neurological, immune, and cardiovascular. Epidemiological evidence from New Zealand claims that consumption of beta-casein A1 is associated with higher national mortality rates from ischaemic heart disease. It seems that the populations that consume milk containing high levels of beta-casein A2 have a lower incidence of cardiovascular disease and type 1 diabetes. BCM-7 has also been suggested as a possible cause of sudden infant death syndrome. In addition, neurological disorders, such as autism and schizophrenia, appear to be associated with milk consumption and a higher level of BCM-7.
Lactose (milk sugar), which is a major component of milk, is a disaccharide sugar made up of the simple sugars glucose and galactose. Lactase is an enzyme which facilitates digestion of lactose. Over 50% of non-Caucasians are lactose intolerant and about 20% of Caucasians. Infants are most lactose tolerant, but lactase activity declines dramatically over time so that by adulthood to about 5 to 10 % of the level of infants. Only a relatively small percentage of people retain enough lactase activity to absorb significant amounts of lactose throughout their adult life. Lactose intolerance results in undigested lactose in the intestines which often causes gas, bloating, abdominal discomfort, and proliferation of bacteria in the intestines. In addition to inhibiting the enzymes, such as peptidases required to digest milk casein and whey, chronic mercury exposure in animals has also been found to inhibit lactase and glucose-6-phosphatase needed to digest lactose and other polysaccharides. Thus chronic exposure to mercury and toxic metals also increases lactose intolerance and digestion problems of carbohydrates in general. Digestive problems have been found to commonly be improved by reducing chronic mercury and toxic metal exposures. Lactose intolerance can also be alleviated to some degree by supplemental enzymes, using fermented milk products such as yogurt or kefir, or using only small amounts of milk products spread throughout the day.
Rat study findings suggest that mercury-induced changes in RT6+ T lymphocytes appear to be related to the development of renal autoimmune insulin-dependent diabetes mellitus disease in genetically predisposed BN rats. Treatment of a strain of rats that are more prone to diabetes than other strains with mercury chloride results in significantly higher incidences of autoimmunity to thyrogobulin and laminin. Mercury has been documented to cause autoimmune conditions like thyroiditis, MS, Lupus, eczema, etc., and people who replace amalgam fillings commonly recover or significantly improve from these conditions.
Another study found that the age or timing of vaccinations containing mercury thimerosal affects the incidence of diabetes in rats. Vanadium, uranium, and other toxic metals have also been found to damage pancreatic islet cells and be a factor in diabetes. Until mercury thimerosal was removed from most vaccines, vaccines were the largest source of mercury in most infants and young children and exposures far more than government health guidelines were common. Dental amalgam has been documented to be the largest source of mercury in most with several amalgam mercury fillings with high typical exposures far more than government health guidelines. Dental amalgam has been documented to be the largest source of mercury in most mothers with several amalgam fillings and the largest prenatal mercury exposure source to the fetus, as well as significant source of mercury exposure in infants.
Mercury causes release of inflammatory cytokines such as Tumor Necrosis Factor-alpha (TNFa) and Interleukin-4, which are documented to be factors in the chronic inflammatory conditions, cell death, and damage to the immune system. TNFa (tumor necrosis factor-alpha) is a cytokine that controls a wide range of immune cell response in mammals, including cell death (apoptosis). Mercury has been shown to induce TNFa, deplete glutathione, and increase glutamate, dopamine, and calcium-related toxicity, causing inflammatory effects and cellular apoptosis in immune cells.
Cell signaling mechanisms like sphingolipids are part of the control mechanism for the TNFa apoptosis mechanism. Glutathione is an amino acid that is a normal cellular mechanism for controlling apoptosis. When glutathione is depleted, reactive oxidative species increased, and CNS and cell signaling mechanisms are disrupted by toxic exposures, such as mercury, neuronal cell apoptosis results and cellular damage. Oxidative stress including methylmercury-induced oxidative stress causes pancreatic beta-cell apoptosis (programmed cell death) and dysfunction. Thimerosal has similar toxicity to methyl mercury and dental amalgam is a significant source of methyl-mercury in those with amalgam fillings.
Both immune cell types Th1 and Th2 cytokine responses are involved in autoimmunity. Mercury has been found to affect both Th1 and Th2 cytokines, causing an increase in inflammatory Th2 cytokines as well as in Th1 cytokines in some circumstances. In the pancreas, the cells responsible for insulin production can be damaged or destroyed by the chronic high levels of cytokines, with the potential of inducing type I or II diabetes—even in otherwise healthy individuals with no other risk factors for diabetes. Mercury inhibits production of insulin and is a factor in diabetes and hypoglycemia, with significant reductions in insulin need after replacement of amalgam fillings and normalizing of blood sugar. Mercury exposure also increases insulin resistance.
Mercury exposure causes an approximately 1.8 fold increase in glucose transport. This glucose transport corresponds with an increase in GLUT 1 glucose transporters. Phosphorylation of p38 kinase increased with mercury exposure. Activation of p38 and an increase in glucose transport corresponding to an increase in GLUT 1 are indicative the induction of a stress response, which can contribute to the induction of insulin resistance in adipocytes. While the magnitude of the action of mercury is modest, its effects were sustained over many days of exposure and impacted subsequent insulin-mediated glucose transport. Pre-treatment with HgCl2 decreased insulin-mediated glucose transport 1.3-fold, suggesting that exposure to mercury may contribute to pathologies associated with glucose homeostasis.
Studies have also found evidence of a connection between low levels of zinc and childhood-onset diabetes. Zinc is an antagonist to toxic metals like cadmium and mercury, and adequate levels are required to balance the adverse effects of these toxic metals on cellular calcium and other enzymatic processes. Mercury reduces the bloods’ ability to transport essential nutrients, such as calcium, magnesium, and zinc, and has an adverse effect on cellular levels of these essential minerals, as well as blocking the function of magnesium and zinc in cellular enzymatic functions. Part of the toxic effects of mercury, cadmium, lead, etc. is through their replacement of essential minerals, such as zinc, at their sites in enzymes, disabling the necessary enzymatic processes. Other connections between mercury and type 1diabetes have also been demonstrated. Mercury inhibits production of insulin and is a factor in diabetes and hypoglycemia, with significant reductions in insulin need after replacement of amalgam fillings and normalizing of blood sugar.
Dr. J. Bart Classen discovered it would be possible to study the effect of Hemophilus B immunization on the incidence of IDDM, using data from a large clinical trial in Finland. Dr. J. Bart Classen and D.C. Classen initiated and funded collaboration with Dr. Tuomilehto in Finland. Amongst all children born in Finland between October 1, 1985 and August 31, 1987, approximately 116,000 were randomized to receive four doses of the HiB vaccine (PPR-D, Connaught) starting at 3 months of life or one dose starting at 24 months of life. Classen and Classen calculated the incidence of IDDM in both groups through age 10 and in a group which did not receive the HiB vaccine—a cohort which included all 128,500 children born in Finland in the 24 months prior to the Hemophilus vaccine study. Immediately following the completion of these two arms, all children born in Finland over a two year period were randomized to receive three doses of the old PPR-D HiB vaccine or three doses of a newer HbOC HiB vaccine.
The data supports published findings that the immunization starting after 2 months of life is associated with an increased incidence of IDDM. Rises in diabetes have been seen in the UK and USA following the introduction of the hemophilus vaccine. Other studies have found that any vaccine that contains mercury or other substances that can induce autoimmunity can cause type I or II diabetes and that vaccinations are a common cause of autoimmunity.
Insulin Resistance Increases Incidence of Neurological Conditions Including Alzheimer’s
Higher insulin and glucose levels in the blood and deficiency of glucose in brain cells that need it have been found to lead to neurological problems, such as Alzheimer’s. Diabetes also impacts memory by increasing the risk that blood vessels will become obstructed, restricting blood flow to the brain. High blood glucose levels also impact cognition through formation of sugar-related toxins called advanced glycation end products (AGEs). AGEs have been found to be factors in aging, diabetes, and Alzheimer’s. Glycotoxins are formed when sugars interact with proteins and lipids, damaging the structure of proteins and membranes and rendering them less able to carry out their many vital processes. Studies have shown that AGEs are key factors in cross-linking of harmful beta-amyloid plaques in the brain that are implicated in Alzheimer’s.
As previously documented, mercury and aluminum exposure increases insulin resistance, and amalgam replacement and detoxification reduce insulin resistance. Studies have also found that supplementation with chromium improves memory performance in individuals with mild memory loss by reducing insulin resistance and increasing ability of cells to use insulin.
Effect of Persistent Organic Pollutants (POPs)
Effects of low-level exposure to some persistent organic pollutants (POPs) was surveyed in a large population (NHANES) survey. There was a strong dose-response relationship between serum concentrations of six selected POPs and the prevalence of diabetes. Diabetes prevalence was strongly positively associated with lipid-adjusted serum concentrations of all six POPs. When the participants were classified according to the sum of category numbers of the six POPs, adjusted odds ratios were strongly significant for trend. The association was consistent in stratified analyses and stronger in younger participants, Mexican Americans, and obese individuals. Systemic detoxification has been found to be effective in reducing the levels of toxic metals and POPs and to lessen related adverse health effects. There are many alternatives for accomplishing this that have been demonstrated to have effectiveness.
Effective Treatment or Control of Diabetes
Authorities referenced here suggest the following measures to
prevent diabetes and insulin resistance:
- lower toxic exposure levels,
- control weight and lose weight if overweight,
- reduce body fat percentage where excessive,
- have regular exercise,
- maintain a good diet using glycemic index or glycemic load information,
- take appropriate supplements in addition to a good multivitamin/multi-mineral supplement, and
- monitor blood glucose level.
For those with several amalgam dental fillings and diabetes, amalgam replacement and detoxification commonly results in significant improvements. Reduced consumption of excitoxins, like MSG and aspartame, and of high fructose corn syrup and other omega 6 oils along with increased consumption of magnesium and omega 3 oils, such as virgin olive oil and coconut oil, have been found to reduce brain inflammation and improve inflammatory conditions like insulin resistance, diabetes, depression, etc. Drugs, such as diuretics, blood pressure medications, steroids for asthma, arthritis, or allergies, prozac, and birth control pills, can increase insulin resistance and blood sugar. Drugs used to treat diabetes such as Avandia and Actos have been found to cause significant increases in cardiovascular disease and heart attacks, as well as increased risk of hip fracture.
Other factors that have been found to be significantly associated with cardiovascular disease and diabetes include daily consumption of soda drinks, diet drinks, fried foods, or a “Western Diet” high in fried foods, refined grains, fast foods, soda, etc. and low in fruits and vegetables. These diet patterns all have been found to be significantly associated with metabolic syndrome, a cluster of cardiovascular disease and diabetes risk factors including elevated waist circumference, high blood pressure, elevated triglycerides, low levels of high-density lipoprotein (HDL or good) cholesterol, clogged arteries, and high fasting glucose levels. The presence of three or more of the factors increases a person’s risk of developing diabetes and cardiovascular disease. Avoidance of these dietary causes of insulin resistance and metabolic syndrome along with exercise, such as walking, have been found to be highly effective at preventing or controlling these conditions. Some carbohydrates elevate blood glucose almost instantly—others much more slowly. The Glycemic Index (GI) is a measure of how quickly carbohydrates elevate glucose. A lower number indicates a slower glucose rise—and better glucose control. Monitoring and avoiding high glycemic foods along with exercise have been found to be effective in controlling insulin resistance.
Oily fish, greens (chlorophyll), and Fenugreek are foods that have been documented to be effective in helping to control insulin resistance. Other foods supportive of controlling blood sugar include foods with high fiber content, whole grain bread, brown rice, dried beans and peas, fresh vegetables and fruit. Glycemic Load (GL) takes into account not only the quality of carbohydrate but also quantity and its effects.
Several studies have documented that lipoic acid (an antioxidant and chelator) resulted in improvement in the majority of diabetes cases it was used for by improving glucose metabolism, increasing insulin sensitivity, and reducing nerve damage (including in diabetic neuropathy). Lipoic acid is also a mercury chelator, commonly used for that purpose.
Several supplements have been found to be significantly effective in promoting healthy blood glucose metabolism. These include Gymnema sylvestre, bitter melon, N-acetyl-cysteine (NAC), Vitamin C and E, Goat’s Rue, Cinnamon, Quercetin, Vanadyl sulfate, Bitter melon, and PolyGycopleX(PGX). Nutrients that have been found effective at blocking AGEs include: Carnosine, Vitamin B1 and B6, NAC, Guava, chromium, Pycnogenol, B7, magnesium, and Yerbamate.
Several types of organ damage can be caused by diabetes/insulin resistance. Diabetic neuropathies are one such. Supplements documented to help with such neuropathies include lipoic acid, vitamin B6 and B12, folic acid, fish oil, and Huckleberry leaf tea. Diabetes can also be a factor in vision problems such as cataracts and diabetic retinopathy. Supplements found to help with these conditions include Taurine, bilberry, lycopene. CAN-C drops (N-acytyl-Carnosine) have been found to be effective at reducing or reversing damage cataracts or other vision problems. Acetyl-L carnitine (ALC) reduces effects and pain of diabetic neuropathy. Supplements found to help with diabetic related kidney damage include Taurine, melatonin, and cranberry proanthocyanidins. Supplements found to help with diabetic related cardiovascular conditions include L-Arginine, L-Carnitine, and hawthorn which can be found in Hawthorne tea or supplements.
Chromium has been found to aid insulin transportation into cells. Cinnamon has been found to lower blood sugar levels. Lipoic acid has been found to improve glucose balance for people with type II diabetes. CoQ10 has cardiovascular benefits and prevents high blood pressure in people with blood glucose control problems.
1. Cohen S. The 24 Hour Pharmacist. Rodale Press; 2008.
2. Roberts C, Vaziri ND, Barnard RJ. Effect of diet and exercise intervention on blood pressure, insulin, oxidative stress, and nitric oxide availability. Circulation. 2002; 106: 2530.
3. Roberts CK, Won D, Pruthi S, et al. Effect of a short-term diet and exercise intervention on oxidative stress, inflammation, MMP-9, and monocyte chemotactic activity in men with metabolic syndrome factors. J Appl Physiol. 2006; 100: 1657-1665.
4. Rolfes SR, Whitney E. Understanding Nutrition. 11th ed. Wadsworth Cengage Learning; 2008: 110-111.
5. Elliott RB, Harris DP, Hill JP, Bibby NJ, Wasmuth HE. Type I (insulin-dependent) diabetes mellitus and cow milk: Casein variant consumption. Diabetologia. 1999; 42(8): 1032.
6. Stanisaw Kamin Anna Cieoeliska1, El Kostyra. Polymorphism of bovine beta-casein and its potential effect on human health. J Appl Genet. 2007; 48(3): 189-198.
7. Sokolov OIu, Kost NV, et al. Regulatory peptides and psychomotor development in infants. Vestn Ross Akad Med Nauk. 2007; (3): 33-9.
8. Sokolov OY, et al. Influence of human B-casomorphin-7 on specific binding of 3H-spiperone to the 5-HT2-receptors of rat brain frontal cortex. Protein Pept Lett. 2006; 13(2): 169-70.
9. Dubynin VA, Malinovskaia IV, et al. Delayed effect of exorphins on learning of albino rat pups. Izv Akad Nauk Ser Biol. 2008; 1: 53-60.
10. Sun Z, Cade R. Findings in normal rats following administration of gliadorphin-7 (GD-7). Peptides. 2003; 24(2): 321-3.
11. Rosenbauer J, Herzig P, Giani G. Early infant feeding and risk of type 1 diabetes mellitus-a nationwide population-based case-control study in pre-school children. Diabetes Metab Res Rev. 2007.
12. Skrodenien E, Mariulionyt D, Padaiga Z, et al. Environmental risk factors in prediction of childhood prediabetes. Medicina(Kaunas). 2008; 44(1): 56-63.
13. Soltesz G, Patterson CC, Dahlquist G. Worldwide childhood type 1 diabetes incidence—What can we learn from epidemiology? Pediatr Diabetes. 2007; 8(6): 6-14.
14. Kosuda LL, Wayne A, Nahounou M, Greiner DL, Bigazzi PE. Reduction of the RT6.2+ subset of T lymphocytes in brown Norway rats with mercury-induced renal autoimmunity. Cell Immunol. 1991; 135(1): 154-67.
15. Barnes DM, Kircher EA. Effects of mercuric chloride on glucose transport in 3T3-L1 adipocytes. Toxicol In Vitro. 2005; 19(2): 207-14.
16. Kroemer G, Hirsch F, Gonzlez-Garcia A, Martinez C. The natural way to heal differential involvement of Th1 and Th2 cytokines in autoimmune diseases. Autoimmunity. 1996; 24(1): 25-33.
17. Hussain S, et al. Mercuric chloride-induced reactive oxygen species and its effect on antioxidant enzymes in different regions of rat brain. J Environ Sci Health B. 1997; 32(3): 395-409.
18. Bulat P. Activity of Gpx and SOD in workers occupationally exposed to mercury. Arch Occup Environ Health. 1998; 71: S37-9.
19. Stohs SJ, Bagchi D. Oxidative mechanisms in the toxicity of metal ions. Free Radic Biol Med. 1995; 18(2): 321-36.
20. Jay D. Glutathione inhibits SOD activity of Hg. Arch Inst Cardiol Mex. 1998; 68(6): 457-61.
21. Tan S, et al. Oxidative stress induces programmed cell death in neuronal cells. J Neurochem. 1998; 71(1): 95-105.
22. Matsuda T, Takuma K, Lee E, et al. Apoptosis of astroglial cells. Nippon Yakurigaku Zasshi. 1998; 112(1): 24P.
23. Lee YW, Ha MS, Kim YK. Role of reactive oxygen species and glutathione in inorganic mercury-induced injury in human glioma cells. Neurochem Res. 2001; 26(11): 1187-93.
24. Ho PI, Ortiz D, Rogers E, Shea TB. Multiple aspects of homocysteine neurotoxicity: glutamate excitotoxicity, kinase hyperactivation and DNA damage. J Neurosci Res. 2002; 70(5): 694-702.
25. Kurek M, Przybilla B, Hermann K, Ring J. An opioid peptide from cows milk, beta-casomorphine-7, is a direct histamine releaser in man. Int Arch Allergy Immunol. 1992; 97(2): 115-20.
26. Tejwani GA, Hanissian SH. Modulation of mu, delta, and kappa opioid receptors in rat brain by metal ions and histidine. Neuropharmology. 1990; 29(5): 445-52.
27. Mondal MS, Mitra S. Inhibition of bovine xanthine oxidase activity by Hg2+ and other metal ions. J Inorg Biochem. 1996; 62(4): 271-9.
28. Ariza ME, Bijur GN, Williams MV. Lead and mercury mutagenesis: Role of H, superoxide dismutase, and xanthine oxidase. Environ. Mol. Mutagen. 1998; 31: 352-361.
29. Naidu BV, Fraga C, Salzman AL, Szabo C, Verrier ED, Mulligan MS. Critical role of reactive nitrogen species in lung ischemia-reperfusion injury. J Heart Lung Transplant. 2003; 22: 784-93.
30. Liaudet L, Szabo G, Szabo C. Oxidative stress and regional ischemia-reperfusion injury: The peroxynitrite—PARP connection. Coronary Artery Dis. 2003; 14: 115-122.
31. Naidu BV, Fraga C, Salzman AL, Szabo C, Verrier ED, Mulligan MS. Critical role of reactive nitrogen species in lung ischemia-reperfusion injury. J Heart Lung Transplant. 2003; 22: 784-93.
32. Vir L, Szab E, Gergely P, Szab C. Peroxynitrite-induced cytotoxicity: mechanisms and opportunities for intervention. Toxicology Letters. 2003; 140: 113-124.
33. Grisham MB, Hernandez LA, Granger DN. Xanthine oxidase and neutrophil infiltration in intestinal ischemia. Am J Physiol. 1986;251 (4.1): G567-74.
34. Sastry KV, Gupta PK. In vitro inhibition of digestive enzymes by heavy metals and their reversal by chelating agents: Part 1, mercuric chloride intoxication. Bull Environ Contam Toxicol. 1978; 20(6): 729-35.
35. Boadi WY, et al. In vitro effect of mercury on enzyme activities. Environ Res. 1992; 57(1): 96-106.
36. Horvath K, Papadimitriou JC, Rabsztyn A, Drachenberg C, Tildon JT. Gastrointestinal abnormalities in children with autistic disorder. J Pediatr. 1999; 135: 559-63.
37. Mc Fadden SA. Phenotypic variation in xenobiotic metabolism and adverse environmental response: focus on sulfur-dependent detoxification pathways. Toxicology. 1996; 111(1-3): 43-65.
38. Markovich, et al. Heavy metals (Hg,Cd) inhibit the activity of the liver and kidney sulfate transporter Sat-1. Toxicol App Pharmacol. 1999; 154(2): 181-7.
39. Matts RL, Schatz JR, Hurst R, Kagen R. Toxic heavy metal ions inhibit reduction of disulfide bonds. J Biol Chem. 1991; 266(19): 12695-702.
40. Perry TL, et al. Hallevorden-Spatz disease: Cysteine accumulation and cysteine dioxygenase deficiency. Ann Neural. 1985; 18(4): 482-489.
41. Ceaurriz, et al. Role of gamma-glutamyltraspeptidase(GGC) and extracellular glutathione in disposition of inorganic mercury. J Appl Toxicol. 1994; 14(3): 201.
42. Shibuya-Saruta H, Kasahara Y, Hashimoto Y. Human serum dipeptidyl peptidase IV (DPPIV) and its unique properties. J Clin Lab Anal. 1996; 10(6): 435-40.
43. Blais A, Morvan-Baleynaud J, Friedlander G, Le Grimellec C. Primary culture of rabbit proximal tubules as a cellular model to study nephrotoxicity of xenobiotics. Kidney Int. 1993; 44(1): 13-8.
44. Puschel G, Mentlein R, Heymann E. Isolation and characterization of dipeptidyl peptidase IV from human placenta. Eur J Biochem. 1982; 126(2): 359-65.
45. Kar NC, Pearson CM. Dipeptyl Peptidases in human muscle disease. Clin Chim Acta. 1978; 82(1-2): 185-92.
46. Seroussi K. Autism and pervasive developmental disorders. 1998: 174.
47. Stefanovic V, et al. Kidney ectopeptidases in mercuric chloride-induced renal failure. Cell Physiol Biochem. 1998; 8(5): 278-84.
48. Crinnion WJ. Environmental toxins and their common health effects. Altern Med Rev. 2000; 5(1): 52-63.
49. Cade JR, et al. Autism and schizophrenia linked to malfunctioning enzyme for milk protein digestion. Autism. 1999.
50. Cade JR, et al. Autism and schizophrenia: Intestinal disorders. Nutritional Neuroscience. 2000.
51. Sun, ZJ, Cade JR, et al. Beta-casomorphin induces Fos-like immunoreactivity in discrete brain regions relevant to schizophrenia and autism. Autism. 1999; 3(1): 67-83.
52. Cade JR, Sun Z. A peptide found in schizophrenia and autism causes behavioral changes in rats. Autism. 1999; 3(1): 85-95.
53. Leboyer M. Opiate hypothesis in infantile autism? Therapeutic trials with naltrexone. Encephale. 1993; 19(2): 95-102.
54. Lucarelli S, et al. Food allergy and infantile autism. Panminerva Med. 1995; 37(3): 137-41.
55. Reichelt KL. Biochemistry and psychophysiology of autistic syndromes. Tidsskr Nor Laegeforen. 1994; 114(12): 1432-4.
56. Reichelt KL, et al. Biologically active peptide-containing fractions in schizophrenia and childhood autism. Adv Biochem Psychopharmocol. 1981; 28: 627-43.
57. Lucarelli S, Cardi E, et al, Food allergy and infantile autism. Panminerva Med. 1995; 37(3): 137-41.
58. Shel L. Autistic disorder and the endogenous opioid system. Med Hypotheses. 1997; 48(5): 413-4.
59. Huebner FR, Lieberman KW, Rubino RP, Wall JS. Demonstration of high opioid-like activity in isolated peptides from wheat gluten hydrolysates. Peptides. 1984; 5(6): 1139-47.
60. Singh MM, Kay SR. Wheat gluten as a pathogenic factor in schizophrenia. Science. 1976; 191(4225): 401-2.
61. Huebner FR,Lieberman KW, Rubino RP, Wall JS. Demonstration of high opioid-like activity in isolated peptides from wheat gluten hydrolysates. Peptides. 1984; 5(6): 1139-47.
62. Horvth K, Graf L, Walcz E, Bodnszky H, Schuler D. Naloxone antagonises effect of alpha-gliadin on leucocyte migration in patients with coeliac disease. Lancet. 1985; 2(8448): 184-5.
63. Stewart-Pinkham, SM. The effect of ambient cadmium air pollution on the hair mineral content of children. The Science of the Total Environment. 1989; 78: 289-96.
64. Kosuda LL, Greiner DL, Bigazzi PE. Effects of HgCl2 on the expression of autoimmune responses and disease in diabetes-prone (DP) BB rats. Autoimmunity. 1997; 26(3): 173-87.
65. Eto K, Yasutake A, Miyamoto K, Tokunaga H, Otsuka Y. Chronic effects of methylmercury in rats. II. Pathological aspects. Tohoku J Exp Med. 1997; 182(3): 197-205.
66. Classen JB. The timing of immunization affects the development of diabetes in rodents. Autoimmunity. 1996; 24: 137-145.
67. Sastry KV, Gupta PK. Changes in the activities of some digestive enzymes, exposed chronically to mercuric chloride. J Environ Sci Health B. 1980; 15(1): 109-19.
68. Knapp LT, Klann E. Superoxide-induced stimulation of protein kinase C via thiol modification and modulation of zinc content. J Biol Chem. 2000.
69. Fukino H. Effect of zinc pretreatment on mercuric chloride-induced lipid peroxidation in the rat kidney. Toxicol Appl Pharmacol. 1984; 73(3): 395-401.
70. Noda M, Wataha JC, Lockwood PE, Volkmann KR, Kaga M, Sano H. Sublethal, 2-week exposures of dental material components alter TNF-alpha secretion of THP-1 monocytes Dent Mater. 2003; 19(2): 101-5.
71. Kim SH, Johnson VJ, Sharma RP. Mercury inhibits nitric oxide production but activates proinflammatory cytokine expression in murine macrophage: differential modulation of NF-kappaB and p38 MAPK signaling pathways. Nitric Oxide. 2002; 7(1): 67-74.
72. Dastych J, Metcalfe DD et al. Murine mast cells exposed to mercuric chloride release granule-associated N-acetyl-beta-D-hexosaminidase and secrete IL-4 and TNF-alpha. J Allergy Clin Immunol. 1999; 103(6): 1108-14.
73. Hide I. Mechanism of production and release of tumor necrosis factor implicated in inflammatory diseases. Nippon Yakurigaku Zasshi. 2003; 121(3): 163-73.
74. Chen L, Nordlind K, Liden S,Sticherling M. Increased expression of keratinocyte interleukin-8 in human contact eczematous reactions to heavy metals. APMIS. 1996; 104(7-8): 509-14.
75. Badou A, et al. HgCl2-induced IL-4 gene expression in T cells involves a protein kinase C-dependent calcium influx through L-type calcium channels. J Biol Chem. 1997; 272(51): 32411-8.
76. Veprintsev DB. Pb2+ and Hg2+ binding to alpha-lactalbumin. Biochem Mol Biol Int. 1996; 39(6): 1255-65.
77. Busselberg D. Calcium channels as target sites of heavy metals. Toxicol Lett. 1995; 82: 255-61.
78. Rajanna B, et al. Modulation of protein kinase C by heavy metals. Toxicol Lett. 1995; 81(2-3): 197-203.
79. Haglund B, Ryckenberg K, Selinus O, Dahlquist G. Evidence of a relationship between childhood-onset diabtes and low groundwater concentration of zinc. Diabetes Care. 1996; 19(8): 873-5.
80. Goyer RA. Toxic and essential metal interactions. Annu Rev Nutr. 1997; 17: 37-50.
81. Goyer RA, et al. Environmental risk factors for osteoporosis. Envir Health Perspectives. 1994; 102(4): 390-394.
82. Lindh U, Carlmark B, Gronquist SO, Lindvall A. Metal exposure from amalgam alters the distribution of trace elements in blood cells and plasma. Clin Chem Lab Med. 2001; 39(2): 134-142.
83. Vojdani A, Pangborn JB, et al. Infections, toxic chemicals and dietary peptides binding to lymphocyte receptors and tissue enzymes are major instigators of autoimmunity in autism. Int J Immunopathol Pharmacol. 2003; 16(3): 189-99.
84. Classen JB. Hemophilus vaccine study in Finland proves a causal relationship between vaccines and diabetes. Autoimmunity. 2002; 35: 247-253.
85. Classen JB. Hemophilus meningitis vaccine proven to cause diabetes in clinical trial of over 100,000 children. Autoimmunity. 2004; 39.
86. Classen JB. The diabetes epidemic and the hepatitis B vaccines. N Z Med J. 1996; 109(1030): 366.
87. Singh I, Pahan K, Khan M, Singh AK. Cytokine-mediated induction of ceramide production is redox-sensitive. Implications to proinflammatory cytokine-mediated apoptosis in demyelinating diseases. J Biol Chem. 1998; 273(32): 20354-62.
88. Pahan K, Raymond JR, Singh I. Inhibition of phosphatidylinositol 3-kinase induces nitric-oxide synthase in lipopolysaccharide- or cytokine-stimulated C6 glial cells. J. Biol. Chem. 1999; 274: 7528-7536.
89. Xu J, Yeh CH, et al. Involvement of de novo ceramide biosynthesis in tumor necrosis factor-alpha/cycloheximide-induced cerebral endothelial cell death. J Biol Chem. 1998; 273(26): 16521-6.
90. Dbaibo GS, El-Assaad W, et al. Ceramide generation by two distinct pathways in tumor necrosis factor alpha-induced cell death. FEBS Lett. 2001; 503(1): 7-12.
91. Liu B, Hannun YA, et al. Glutathione regulation of neutral sphingomyelinase in tumor necrosis factor-alpha-inducedcell death. J Biol Chem. 1998; 273(18): 11313-20.
92. Van Lieburg, et al. Discovery of aquaporins: A breakthrough in research on renal water transport. Pediatr Nephrol. 1995; 9(2): 228-34.
93. Van Lieburg AF, Knoers NV, Deen P. Importance of the mercury-sensitive cysteine on function and routing of AQP1 and AQP2 in oocytes. Am J Physiol. 1997; 273(3.2): F451-6.
94. Langworth, et al. Effects of low exposure to inorganic mercury on the human immune system. Scand J Work Environ Health. 1993; 19(6): 405-413.
95. Walum E, et al. Use of primary cultures to study astrocytic regulatory functions. Clin Exp Pharmoacol Physiol. 1995; 22: 284-7.
96. Kerkhoff H, Troost D, Louwerse ES. Infammatory cells in the peripheral nervous system in motro neuron disease. Acta Neuropathol. 1993; 85: 560-5.
97. Appel Sh, Smith RG. Autoimmunity as an etiological factor in amyotrophic lateral sclerosis. Adv Neurol. 1995; 68: 47-57.
98. Mathieson PW. Mercury: God of TH2 cells. Clinical Exp Immunol. 1995; 102(2): 229-30.
99. Heo Y, Parsons PJ, Lawrence DA. Lead differentially modifies cytokine production in vitro and in vivo. Toxicol Appl Pharmacol. 1996; 138: 149-57.
100. Murdoch RD, Pepys J. Enhancement of antibody and IgE production by mercury and platinum salts. Int Arch Allergy Appl Immunol. 1986; 80: 405-11.
101. Parronchi P, Brugnolo F, Sampognaro S, Maggi E. Genetic and environmental factors contributing to the onset of allergic disorders. Int Arch Allergy Immunol. 2000; 121(1): 2-9.
102. Fabbri E, Caselli F, Piano A, Sartor G, Capuzzo A. Cd2+ and Hg2+ affect glucose release and cAMP-dependent transduction pathway in isolated eel hepatocytes. Aquat Toxicol. 2003; 62(1): 55-65.
103. Bapu C, Purohit RC, Sood PP. Fluctuation of trace elements during methylmercury toxication and chelation therapy. Hum Exp Toxicol. 1994; 13(12): 815-23.
104. West ES, et al. Textbook of Biochemistry. MacMillan Co; 1957: 853.
105. Perlingeiro RC, et al. Polymorphonuclear phagentosis in workers exposed to mercury vapor. Int J Immounopharmacology. 1994; 16(12): 1011-7.
106. Albers JW, et al. Neurological abnormalities associated with remote occupational elemental mercury exposure. Ann Neurol. 1988; 24(5): 651-9.
107. Soleo L, et al. Effects of low exposure to inorganic mercury on psychological performance. Br J Ind Med. 1990; 47(2): 105-9.
108. Smith PJ, et al. Effect of exposure to elemental mercury on short term memory. Br J Ind Med. 1983; 40(4): 413-9.
109. Hua MS, et al. Chronic elemental mercury intoxication. Brain Inj. 1996; 10(5): 377-84.
110. Gunther W, et al. Repeated neurobehavioral investigations in workers. Neurotoxicology. 1996; 17(3-4): 605-14.
111. Levine SP, Cavender GD, Langolf GD, Albers JW. Elemental mercury exposure: peripheral neurotoxicity. Br J Ind Med. 1982; 39(2): 136-9.
112. Boadi WY, et al. In vitro effect of mercury on enzyme activities and its accumulation in the first-trimester human placenta. Environ Res. 1992; 57(1): 96-106.
113. Urbach J, et al. Effect of inorganic mercury on in vitro placental nutrient transfer and oxygen consumption. Reprod Toxicol. 1992; 6(1): 69-75.
114. Karp W, Gale TF, et al. Effect of mercuric acetate on selected enzymes of maternal and fetal hamsters. Environmental Research. 1985; 36: 351-358.
115. Karp WB, et al. Correlation of human placental enzymatic activity with trace metal concentration in placenta. Environmental Research. 1977; 13: 470- 477.
116. Boot JH. Effects of SH-blocking compounds on the energy metabolism and glucose uptake in isolated rat hepatocytes. Cell Struct Funct. 1995; 20(3): 233-8.
117. Sterzl I, Prochazkova J, Stejskal VDM, et al. Mercury and nickel allergy: Risk factors in fatigue and autoimmunity. Neuroendocrinology Letters. 1999; 20: 221-228.
118. Prochazkova J, Sterzl I, Kucerova H, Bartova J, Stejskal VD. The beneficial effect of amalgam replacement on health in patients with autoimmunity. Neuroendocrinology Letters. 2004; 25(3): 211-8.
119. Romani L. Immunity to candida albicans: Th1,Th2 cells and beyond. Curr Opin Microbiol. 1999; 2(4): 363-7.
120. Munch G, Gerlach M, Sian J, Wong A, Riederer P. Advanced glycation end products in neurodegeneration: more than early markers of oxidative stress? Ann Neurol. 1998; 44(3.1): S85-8.
121. Hu H, Moller G, Abedi-Valugerdi M. Mechanism of Mercury-induced autoimmunity: Both T helper 1 and T helper 2 & type responses are involved. Immunology. 1999; 96(3): 348-57.
122. Estevez AG, Beckman JS, et al. Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase. Science. 1999; 286(5449): 2498-500.
123. Valko M, Morris H, Cronin MT. Metals, toxicity and oxidative stress. Curr Med Chem. 2005; 12(10): 1161-208.
124. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007; 39(1): 44-84.
125. Kajimoto Y, Kaneto H. Role of oxidative stress in pancreatic beta-cell dysfunction. Ann. N. Y. Acad. Sci. 2004; 1011: 168-176.
126. Kobayashi MS, Han D, Packer L. Antioxidants and herbal extracts protect HT-4 neuronal cells against glutamate-induced cytotoxicity. Free Radical Research. 2000; 32(2): 115-24.
127. Li Y, Liu L, Barger SW, Mrak RE, Griffin WS. Vitamin E suppression of microglial activation is neuroprotective. J Neurosci Res. 2001; 66(2): 163-70.
128. Doble A. The role of excitotoxicity in neurodegenerative disease: implications for therapy. Pharmacol Ther. 1999; 81(3): 163-221.
129. D Lee, B Baker, D Jacobs, et al. A strong dose-response relation between serum concentrations of persistent organic pollutants and diabetes: Results from the National Health and Examination Survey 1999-2002. Diabetes Care. 2006; 29(7): 1638-1644.
130. Classen B. Vaccines are the largest cause of insulin-dependent diabetes in young children. Paper given at American College for Advancement in Medicine. Nashville, TN. 2001.
131. Narayan KMV, Boyle JP. Lifetime risk for diabetes mellitus in the U.S. JAMA. 2003; 290(14): 1884-90.
132. Chang JW, Su HJ, Liao PC, et al. Simultaneous exposure of non-diabetics to high levels of dioxins and mercury increases their risk of insulin resistance. J Hazard Mater. 2011; 185(2-3): 749-55.
133. Stengler M. Bad Drugs, Good Alternatives. Bottom Line Publishing; 2010.
134. Babizhayev M. Lipid peroxidation as a possible cause of human cataracts. N-acetylcarnosine as a potent ophthalmic drug for the treatment of human cataracts. Lecture. 3rd Monte Carlo Anti-Aging Conference.
135. Babizhayev M, et al. N-acetylcarnosine, a natural histidine-containing dipeptide, as a potent ophthalmic drug in treatment of human cataracts. Peptides. 2001; 22(6): 979-994.
136. Babizhayev M. Imidazole containing peptidomimetic NACA as a potent drug for the medicinal treatment of age-related cataract in humans. Journal of Anti-Aging Medicine. 2000; 3(1): 43-62.
137. Babizhayev M. The natural histidine-containing dipeptide N-alpha-acetylcarnosine as an antioxidant for ophthalmic use. Biochemistry. 2000; 65(5).
138. Babizhayev M. N-alpha acetylcarnosine is a prodrug of L-carnosine in ophthalmic application as antioxidant. Clin Chim Acta. 1996; 254(1): 1-21.
139. Babizhayev M. Lipid peroxidation as a possible cause of cataract. Mech. Ageing Dev. 1988; 44(1): 69-89.
140. Lutsey PL, Steffen LM. Dietary intake and the development of the metabolic syndrome: The atherosclerosis risk in communities study. Circulation. 2008.
141. Mendler MH, Turlin B, Moirand R, et al. Insulin resistance-associated hepatic iron overload. Gastroenterology. 1999; 117(5): 1155-63.
142. Dandona P. Effects of antidiabetic and antihyperlipidemic agents on C-reactive protein. Mayo Clin Proc. 2008; 83(3): 333-42.
143. Vasdev S, Gill V, Singal P. Role of advanced glycation end products in hypertension and atherosclerosis: therapeutic implications. Cell Biochem Biophys. 2007; 49(1): 48-63.
144. Barnes DM, Kircher EA. Effects of mercuric chloride on glucose transport in 3T3-L1 adipocytes. Toxicol In Vitro. 2005; 19(2): 207-14.
145. Barnes DM, Hanlon PR, Kircher EA. Effects of inorganic HgCl2 on adipogenesis. Toxicol Sci. 2003; 75(2): 368-77.
146. Iturri SJ, Pentilde A. Heavy metal-induced inhibition of active transport in the rat small intestine in vitro: Interaction with other ions. Comp Biochem Physiol C. 1986; 84(2): 363-8.
147. Klip A, Grinstein S, Biber J, Semenza G. Interaction of the sugar carrier of intestinal brush-border membranes with HgCl2. Biochim Biophys Acta. 1980; 598(1): 100-14.
148. Rayssiguier Y, Gueux E, et al. High fructose consumption combined with low dietary magnesium intake may increase the incidence of the metabolic syndrome by inducing inflammation. Magnes Res. 2006; 19(4): 237-43.
149. Bo S, Durazzo M, Pagano G, et al. Dietary magnesium and fiber intakes and inflammatory and metabolic indicators in middle-aged subjects from a population-based cohort. Am J Clin Nutr. 2006; 84(5): 1062-9.
150. Guerrero-Romero F, Rodriguez-Moran. Hypomagnesemia, oxidative stress, inflammation, and metabolic syndrome. Diabetes Metab Res Rev. 2006; 22(6): 471-6.